Abstract
GIP is a peptide hormone of therapeutic interest in type 2 diabetes and obesity. This study evaluated pGIP/neo STC-1 as a potential K-cell model for studying GIP secretion.
| Original language | English |
|---|---|
| Pages (from-to) | 1683-6 |
| Number of pages | 4 |
| Journal | Metabolism |
| Volume | 61 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 2012 |
Bibliographical note
Copyright © 2012 Elsevier Inc. All rights reserved.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism
Fingerprint
Dive into the research topics of 'Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver